Ariceum Therapeutics Funding: $48M Raised, Series A (2023)
Ariceum Therapeutics is based in Berlin, Germany. It has raised $48M in total funding. Latest round: Series A.
Ariceum Therapeutics funding overview
Ariceum Therapeutics is based in Berlin, Germany. Ariceum Therapeutics has raised $48M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in April 2023. The round record for Ariceum Therapeutics runs through 2023; nothing later has been disclosed. Investors on record include EQT Life Sciences, HealthCap, Andera Partners, Earlybird Venture Capital. 4 distinct backers are named across the disclosed rounds.
Ariceum Therapeutics at a glance
Total raised
$48M
Latest round
Series A
Latest round date
April 2023
Headquarters
Berlin, Germany
Notable investors
EQT Life Sciences, HealthCap, Andera Partners, Earlybird Venture Capital
Frequently asked about Ariceum Therapeutics funding
How much has Ariceum Therapeutics raised?
Ariceum Therapeutics has raised $48M in total disclosed funding across the rounds on record.
Who has invested in Ariceum Therapeutics?
EQT Life Sciences, HealthCap, Andera Partners, Earlybird Venture Capital are named among the investors backing Ariceum Therapeutics.
What was the latest Ariceum Therapeutics funding round?
The most recent disclosed round is a Series A, announced in April 2023.
Where is Ariceum Therapeutics based?
Ariceum Therapeutics is based in Berlin, Germany.
When did Ariceum Therapeutics last raise?
The last disclosed Ariceum Therapeutics round closed in April 2023 at Series A.
Ariceum Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Berlin below to benchmark round size and investor mix.
